Delivery Order SPE2DB22D1017-SPE2DB25FG9MN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AREXVY vial kits, with a ceiling value of $1,440.44. This firm fixed-price delivery order, awarded on July 30, 2025, represents a competitively awarded contract with no set-aside designation and is scheduled for ultimate completion by July 31, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,168.96 delivery order for AREXVY vial kits under contract 4568853131 on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement to support federal medical supply requirements. The contract will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,707.89 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for AREXVY VIAL KITS. This order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp that has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC allows Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AREXVY VIAL KITS. The contract has a potential value of $1,707.90 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $17,585.30 to AmerisourceBergen Drug Corp on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order was placed with AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,623.36 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,191.66 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued under contract number 4569059988, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,264.90 to AmerisourceBergen Drug Corp on August 5, 2025, with a completion deadline of August 6, 2025. This firm fixed-price delivery order, classified as a child contract under the company's larger indefinite delivery vehicle with DLA Troop Support Medical, represents a competitively awarded, non-set-aside transaction. The award was made to AmerisourceBergen's Corporate Office division, headquartered...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9MNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,440.44 to AmerisourceBergen Drug Corp for AREXVY vial kits on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, this delivery order represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's broader IDC vehicle enables supply of a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for AREXVY vial kits reflects the company's ongoing capability to fulfill federal medical supply requirements through open competition and demonstrates the flexibility of the prime vendor contract structure in supporting diverse military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/12/25 |